These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35060345)

  • 21. Role of Myeloma-Derived MIF in Myeloma Cell Adhesion to Bone Marrow and Chemotherapy Response.
    Zheng Y; Wang Q; Li T; Qian J; Lu Y; Li Y; Bi E; Reu F; Qin Y; Drazba J; Hsi E; Yang J; Cai Z; Yi Q
    J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27381622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta.
    Onodera S; Nishihira J; Koyama Y; Majima T; Aoki Y; Ichiyama H; Ishibashi T; Minami A
    Arthritis Rheum; 2004 May; 50(5):1437-47. PubMed ID: 15146413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissociation of MIF-rpS3 complex and sequential NF-κB activation is involved in IR-induced metastatic conversion of NSCLC.
    Youn H; Son B; Kim W; Jun SY; Lee JS; Lee JM; Kang C; Kim J; Youn B
    J Cell Biochem; 2015 Nov; 116(11):2504-16. PubMed ID: 25900216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blocking Macrophage Migration Inhibitory Factor Protects Against Cisplatin-Induced Acute Kidney Injury in Mice.
    Li J; Tang Y; Tang PMK; Lv J; Huang XR; Carlsson-Skwirut C; Da Costa L; Aspesi A; Fröhlich S; Szczęśniak P; Lacher P; Klug J; Meinhardt A; Fingerle-Rowson G; Gong R; Zheng Z; Xu A; Lan HY
    Mol Ther; 2018 Oct; 26(10):2523-2532. PubMed ID: 30077612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrophage migration inhibitory factor increases cell motility and up-regulates αvβ3 integrin in human chondrosarcoma cells.
    Lee CY; Su MJ; Huang CY; Chen MY; Hsu HC; Lin CY; Tang CH
    J Cell Biochem; 2012 May; 113(5):1590-8. PubMed ID: 22174124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Theabrownin inhibits the cytoskeleton‑dependent cell cycle, migration and invasion of human osteosarcoma cells through NF‑κB pathway‑related mechanisms.
    Jin W; Gu C; Zhou L; Yang X; Gui M; Zhang J; Chen J; Dong X; Yuan Q; Shan L
    Oncol Rep; 2020 Dec; 44(6):2621-2633. PubMed ID: 33125106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA NKILA inhibits invasion and migration of osteosarcoma cells via NF-κB/Snail signaling pathway.
    Zhang GD; Li Y; Liao GJ; Qiu HW
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4118-4125. PubMed ID: 31173281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of neuroinflammation by MIF inhibitor 3-({[4-(4-methoxyphenyl)-6-methyl-2-pyrimidinyl]thio}1methyl)benzoic acid (Z-312).
    Zheng LT; Chen J; Zhang L; Zhang Y; Xu L; Hou T; Zhen X; Dai Q; Liu H
    Int Immunopharmacol; 2021 Sep; 98():107868. PubMed ID: 34153665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of Macrophage Migration Inhibitory Factor Protects against Inflammation through a Toll-like Receptor-Related Pathway after Diffuse Axonal Injury in Rats.
    Zhao Y; Wei X; Li W; Shan C; Song J; Zhang M
    Biomed Res Int; 2020; 2020():5946205. PubMed ID: 32964038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MIF-mediated NF-κB signaling pathway regulates the pathogenesis of polycystic ovary syndrome in rats.
    He Z; Wang Y; Zhuan L; Li Y; Tang ZO; Wu Z; Ma Y
    Cytokine; 2021 Oct; 146():155632. PubMed ID: 34242901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-451 suppresses proliferation, migration and promotes apoptosis of the human osteosarcoma by targeting macrophage migration inhibitory factor.
    Liu W; Liu SY; He YB; Huang RL; Deng SY; Ni GX; Yu B
    Biomed Pharmacother; 2017 Mar; 87():621-627. PubMed ID: 28086136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral squamous carcinoma cells promote macrophage polarization in an MIF-dependent manner.
    Barbosa de Souza Rizzo M; Brasilino de Carvalho M; Kim EJ; Rendon BE; Noe JT; Darlene Wise A; Mitchell RA
    QJM; 2018 Nov; 111(11):769-778. PubMed ID: 30016493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophage migration inhibitory factor down-regulates the RANKL-RANK signaling pathway by activating Lyn tyrosine kinase in mouse models.
    Mun SH; Oh D; Lee SK
    Arthritis Rheumatol; 2014 Sep; 66(9):2482-93. PubMed ID: 24891319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ezrin/NF-κB Pathway Regulates EGF-induced Epithelial-Mesenchymal Transition (EMT), Metastasis, and Progression of Osteosarcoma.
    Liu P; Yang P; Zhang Z; Liu M; Hu S
    Med Sci Monit; 2018 Apr; 24():2098-2108. PubMed ID: 29628496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene knockout or inhibition of macrophage migration inhibitory factor alleviates lipopolysaccharide-induced liver injury via inhibiting inflammatory response.
    Gu YL; Xiao LL; Li DJ; Liu YN; Zhu CJ; Zhang SJ
    Hepatobiliary Pancreat Dis Int; 2021 Oct; 20(5):469-477. PubMed ID: 34348873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage migration inhibitory factor is regulated by HIF-1α and cAMP and promotes renal cyst cell proliferation in a macrophage-independent manner.
    Safi W; Kraus A; Grampp S; Schödel J; Buchholz B
    J Mol Med (Berl); 2020 Nov; 98(11):1547-1559. PubMed ID: 32885302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulforaphene inhibits the progression of osteosarcoma via regulating FSTL1/NF-κB pathway.
    Zhang G; Jin C; Zhu Y; Fu F; Wang G; Li S
    Life Sci; 2020 Dec; 263():118485. PubMed ID: 33017573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of macrophage migration inhibitory factor impairs the growth properties of human HeLa cervical cancer cells.
    Xiao DZ; Dai B; Chen J; Luo Q; Liu XY; Lin QX; Li XH; Huang W; Yu XY
    Cell Prolif; 2011 Dec; 44(6):582-90. PubMed ID: 21991924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MIF/CD74 axis is a target for novel therapies in colon carcinomatosis.
    Bozzi F; Mogavero A; Varinelli L; Belfiore A; Manenti G; Caccia C; Volpi CC; Beznoussenko GV; Milione M; Leoni V; Gloghini A; Mironov AA; Leo E; Pilotti S; Pierotti MA; Bongarzone I; Gariboldi M
    J Exp Clin Cancer Res; 2017 Jan; 36(1):16. PubMed ID: 28114961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting distinct tautomerase sites of D-DT and MIF with a single molecule for inhibition of neutrophil lung recruitment.
    Rajasekaran D; Zierow S; Syed M; Bucala R; Bhandari V; Lolis EJ
    FASEB J; 2014 Nov; 28(11):4961-71. PubMed ID: 25016026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.